AcelRx Pharmaceuticals, Inc. ACRX
0.86 0.00 (+0.00%)
At closeJan 9, 2024, 4:00 PM EST
0.7784 Day range 0.875
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 4.63 +438.4% upside
Now 0.86
- Target (low)
- 4.25
- Target (mean)
- 4.63
- Target (high)
- 5.00
Ratings (0m) 5 3 buy · 2 hold · 0 sell
- Strong buy0
- Buy3
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 2
- 2 months ago 2
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.18 | -0.21 – -0.16 | -1.00 | +82.0% | 280.00K | +11.1% | 2 |
| Next quarter | -0.24 | -0.24 – -0.24 | -0.75 | +68.0% | 0 | 0.0% | 1 |
| Current year | -1.18 | -1.18 – -1.18 | 5.72 | -120.6% | 510.00K | -71.2% | 1 |
| Next year | -0.78 | -0.78 – -0.78 | -1.18 | +33.9% | 1.36M | +166.7% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 2023 | Alliance Global Partners | Initiated | — | Buy |
| Sep 24, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 17, 2023 | HC Wainwright & Co. | Upgrade | Neutral | Buy |